These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3919989)

  • 21. Effects of theophylline on breathlessness and exercise tolerance in patients with chronic airflow obstruction.
    Eaton ML; MacDonald FM; Church TR; Niewoehner DE
    Chest; 1982 Nov; 82(5):538-42. PubMed ID: 7128220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Theophylline kinetics in acute pulmonary edema.
    Piafsky KM; Sitar DS; Rangno RE; Ogilvie RI
    Clin Pharmacol Ther; 1977 Mar; 21(3):310-6. PubMed ID: 837650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of rifampin on theophylline kinetics.
    Boyce EG; Dukes GE; Rollins DE; Sudds TW
    J Clin Pharmacol; 1986; 26(8):696-9. PubMed ID: 3793963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous aminophylline in the treatment of acute bronchospastic exacerbations of chronic obstructive pulmonary disease.
    Seidenfeld JJ; Jones WN; Moss RE; Tremper J
    Ann Emerg Med; 1984 Apr; 13(4):248-52. PubMed ID: 6367554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Theophylline concentrations in patients with acute exacerbation of COPD.
    Emerman CL; Connors AF; Lukens TW; May ME; Effron D
    Am J Emerg Med; 1990 Jul; 8(4):289-92. PubMed ID: 2363749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonlinear regression program to individualize oral theophylline dosage.
    Bauer LA; Black DJ; Koup JR
    Clin Pharm; 1984; 3(3):288-90. PubMed ID: 6547379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid estimation of total body clearance of theophylline in patients receiving intravenous aminophylline infusion.
    Lau AH; O'Connor T; Lam G; Lui CY; Al-Bazzaz FJ; Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):12-5. PubMed ID: 3957483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease.
    Tsukino M; Nishimura K; Ikeda A; Hajiro T; Koyama H; Izumi T
    Thorax; 1998 Apr; 53(4):269-73. PubMed ID: 9741369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of three antibiotics on theophylline kinetics.
    Pfeifer HJ; Greenblatt DJ; Friedman P
    Clin Pharmacol Ther; 1979 Jul; 26(1):36-40. PubMed ID: 445960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.
    Jenne JW; Wyze MS; Rood FS; MacDonald FM
    Clin Pharmacol Ther; 1972; 13(3):349-60. PubMed ID: 5026376
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of tetracycline on theophylline disposition in patients with chronic obstructive airways disease.
    Gotz VP; Ryerson GG
    Drug Intell Clin Pharm; 1986 Sep; 20(9):694-7. PubMed ID: 3757782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence of oxidative stress in asthma and COPD: potential inhibitory effect of theophylline.
    Tsukagoshi H; Shimizu Y; Iwamae S; Hisada T; Ishizuka T; Iizuka K; Dobashi K; Mori M
    Respir Med; 2000 Jun; 94(6):584-8. PubMed ID: 10921764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the bronchodilating effect of two doses of a sustained release theophylline.
    Prignot J; Delaunois L; Lulling J; Delwiche JP; Vandenplas F
    Respiration; 1984; 46(2):166-73. PubMed ID: 6436935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
    Fontana G; Cresci F; Lo Sapio P; Panuccio P
    Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronopharmacodynamics and kinetics after symmetric and asymmetric multiple theophylline doses in patients with chronic obstructive pulmonary disease.
    Gimeno F; van Veenen R; Berg WC; Steenhuis EJ; Jonkman JH; Weibel MA
    Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):7-12. PubMed ID: 2744908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of doxofylline versus theophylline on sleep architecture in COPD patients.
    Sacco C; Braghiroli A; Grossi E; Donner CF
    Monaldi Arch Chest Dis; 1995 Apr; 50(2):98-103. PubMed ID: 7613555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of intravenous theophylline in pregnant patients at term.
    Romero R; Kadar N; Gonzales Govea F; Hobbins JC
    Am J Perinatol; 1983 Oct; 1(1):31-5. PubMed ID: 6680648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Influence of the combination of theophylline and beta 2 agonists by oral route on pulmonary function of patients with chronic obstructive lung disease].
    Carvalho-Pinto RM; Terra Filho M; Cukier A; Santos SR; Verrastro C; Teixeira LR; Vargas FS
    Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(4):166-9. PubMed ID: 1843713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Theophylline kinetics in a geriatric group.
    Fox RW; Samaan S; Bukantz SC; Lockey RF
    Clin Pharmacol Ther; 1983 Jul; 34(1):60-7. PubMed ID: 6861439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of theophylline clearance by oral activated charcoal.
    Berlinger WG; Spector R; Goldberg MJ; Johnson GF; Quee CK; Berg MJ
    Clin Pharmacol Ther; 1983 Mar; 33(3):351-4. PubMed ID: 6337763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.